Department of Periodontology, Universitat International de Catalunya, 08017 Barcelona, Spain.
Clinica Dental Herrero Climent, Calle del Dr. Fleming 54, 28036 Madrid, Spain.
Int J Environ Res Public Health. 2021 Jan 29;18(3):1223. doi: 10.3390/ijerph18031223.
Implant dentistry has evolved over time, resulting in better treatment outcomes for both patients and clinicians. The aim of this trial was to test whether the immediate loading of implants with a platform-switching design influences the marginal bone level, compared to four-week loading, after one year of follow-up. Moreover, a comparison of clinical data regarding implant survival, implant stability, and patient-reported outcome measures (PROMs) was conducted. Klockner VEGA implants with a ContacTi surface were placed in partially edentulous patients in the posterior areas. Group A received an immediately loaded prosthesis (one week) and Group B received an early-loaded prosthesis (four weeks). All abutments were placed at the time of surgery. Radiographic and clinical data were recorded. Twenty-one patients were treated (35 implants). No implants were lost during the study. The final marginal bone level did not show differences between groups. The bone loss at 12 months at the implant level was 0.00 mm for both groups (median). The final implant quotient stability (ISQ) values did not differ between groups (median 73 and 70.25), nor did the other clinical parameters or PROMs. : The results suggest that neither of the loading protocols with the implants used influenced the marginal bone level-not the osseointegration rate, clinical conditions, or PROMs.
种植体牙科随着时间的推移而发展,为患者和临床医生带来了更好的治疗效果。本试验的目的是测试在一年的随访后,与四星期负重相比,平台转换设计的种植体即刻负重是否会影响边缘骨水平。此外,还对有关种植体存活率、种植体稳定性和患者报告的结果测量(PROMs)的临床数据进行了比较。Klockner VEGA 种植体采用 ContacTi 表面,植入在后牙区的部分缺牙患者中。A 组接受即刻负重修复体(一周),B 组接受早期负重修复体(四周)。所有基台均在手术时放置。记录放射学和临床数据。21 名患者接受了治疗(35 个种植体)。研究过程中没有种植体丢失。两组的最终边缘骨水平没有差异。两组的种植体水平 12 个月时的骨损失均为 0.00 毫米(中位数)。两组的最终种植体商稳定(ISQ)值没有差异(中位数分别为 73 和 70.25),其他临床参数和 PROMs 也没有差异。结果表明,使用的两种种植体负重方案均未影响边缘骨水平,即骨整合率、临床状况或 PROMs 不受影响。